MoonLake Immunotherapeutics says U.S. FDA accepts MIRA and VELA-TEEN trial data for sonelkimab BLA submission

Published: 2026-05-10 09:04:17 ET MLTX

Published on 05/10/2026 at 09:04 am EDT